Table 1.
Clinical, laboratory, molecular and treatment characteristics and outcome of 28 patients with de novo mast cell leukemia (MCL, n=16) or secondary MCL (n=12).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.